Table 1.
Demographic and clinical variables
| Demographic and clinical variables | Na (%) | |
|---|---|---|
| Gender | Female | 1663 (81.1) |
| Male | 388 (18.9) | |
| Age groups | 18–39 years | 648 (32.4) |
| 40–49 years | 665 (33.2) | |
| >49 years | 690 (34.4) | |
| Country of residence | United States of America | 691 (33.5) |
| Australia | 526 (25.5) | |
| United Kingdom | 339 (16.4) | |
| 51 other countries | 506 (24.5) | |
| Marital status | Married, cohabitating or partnered | 1589 (78.1) |
| Single/separated/widowed | 447 (22.0) | |
| Children | None | 611 (30.0) |
| One or more | 1424 (70.0) | |
| Education | High school or below | 498 (24.3) |
| Vocational training | 338 (16.5) | |
| University | 1218 (59.3) | |
| Employment | Part or full time employed | 1127 (54.8) |
| Retired due to age or disability | 521 (25.3) | |
| Other | 409 (19.9) | |
| Type of MS | Relapsing remitting | 1290 (62.8) |
| Primary progressive | 140 (6.8) | |
| Secondary progressive | 225 (11.0) | |
| Other/unknown | 398 (19.4) | |
| Years since diagnosis | (Median and interquartile range) | 6 (3–12) |
| Level of disability | None-mild | 1151 (56.2) |
| Moderate | 698 (34.1) | |
| Severe | 200 (9.8) | |
| Clinical fatigue | Yes | 1255 (65.7) |
| No | 656 (34.3) | |
| Positive screen for depression | Yes | 377 (19.0) |
| No | 1607 (81.0) | |
| Taking antidepressants | Yes | 456 (22.5) |
| No | 1571 (77.5) | |
| Currently using disease modifying drug | Yes | 1039 (51.3) |
| No | 988 (48.7) | |
aN varies due to non-completion